Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
400 participants
OBSERVATIONAL
2018-12-27
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The prediction will be based on multiple measurements, including blood tests, personal lifestyle and gut microbiome. This will allow investigators to design personalized Mediterranean machine-learning-based diets which may potentially reduce the burden of disease in adulthood as well as the burden of obesity in the pediatric age.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recently, the investigators developed an algorithm enabling to predict the personalized postprandial glucose responses to food in adult healthy individuals. However, personalized nutrition was never tested on children.
In this study, children will be followed up in different bio-geographical locations. The primary aim of the study is to develop specific pediatric algorithms for predicting the personalized glucose response to food for individual children. This prediction will be based on multiple measurements, including blood and urine tests, anthropometric measurements, personal lifestyle and gut microbiome. This may allow the investigators to design personalized Mediterranean algorithm-based diets which may potentially reduce the burden of non-communicable disease in adulthood as well as the burden of obesity in the pediatric age.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 6-11 years of age
* Tanner 1
Exclusion Criteria
* Chronic illness in the past 5 years, including inflammatory, metabolic, neoplastic, congenital and infectious disease.
* Use of medications (e.g. Antibiotics/antifungal, PPI, analgesics) and any antibiotics 3 months prior to the first visit, PPI one month prior to the beginning of the study or use of medication during the study.
* Treatment with anti-diabetic medications;
* Neuro-psychiatric disorders
* Cancer and recent anticancer treatment
* Eating disorders (Anorexia nervosa. Bulimia nervosa. Binge eating disorder, Night eating syndrome).
* Inability of the participant and/or nuclear family to follow and utilize the smartphone application.
* Dietary restrictions or specific dietary regimen
6 Years
11 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Schneider Children's Medical Center, Israel
OTHER
University of Naples
OTHER
Weizmann Institute of Science
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eran Elinav
Prof. Eran Elinav
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eran Elinav, Prof
Role: PRINCIPAL_INVESTIGATOR
Weizmann Institute of Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Weizmann Institute of Science
Rehovot, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
aurelie Bukimer mimran
Role: primary
Shimrit Eliyahu miller
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0694-17-RMC
Identifier Type: -
Identifier Source: org_study_id